By Topic

Regeneration of Smooth Muscle Cells from Bone Marrow - Use of Mesenchymal Stem Cells for Tissue Engineering and Cellular Therapeutics

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

7 Author(s)
Nan Wang ; Key Lab. of Ind. Microbiol., Tianjin Univ. of Sci. & Technol., Tianjin, China ; Linlin Ma ; Zhen Zhou ; Junyun Zhang
more authors

Bone marrow mesenchymal stem cells (MSCs) can differentiate into smooth muscle cells (SMCs) and have tremendous potential for cell therapy and tissue engineering. In this study, to understand the effects of TGF-beta3 on rat bone marrow-derived MSCs and the underlying molecular mechanism of this differentiation process, we investigated that the changes of myocardin-related transcription factors (MRTFs) at the transcriptional level after rat MSCs were treated with TGF-beta3. The results showed that TGF-beta3 increased the expression of contractile genes, such as SM22, smooth muscle-myosin heavy chain (SM-MHC), SM-alpha-actin in MSCs. When TGF-beta3 induced MSCs differentiation into SMCs, myocardin and MRTF-A were activated. The data indicated that TGF-betai3 induced rat bone marrow-derived MSCs differentiation into SMCs by activating mypcardin and MRTF-A.

Published in:

2009 3rd International Conference on Bioinformatics and Biomedical Engineering

Date of Conference:

11-13 June 2009